SUBSCRIBE
SUBSCRIBE

Asia

Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Takeda and Teva Establish New Biz Venture “Teva Takeda Yakuhin Ltd.” for Japanese Generics
April 1, 2016
 · 
2 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Deals
Sun Pharma Snaps Up 14 Japanese Brands From Novartis AG in $293 Million Deal
March 30, 2016
 · 
2 min read
A Medical Device That Can Conduct 33 Diagnostic Tests In Just 45 Minutes
March 29, 2016
 · 
1 min read
Meet The Israeli Startup That Could Stomp Out Malaria In Africa And India, Sight Diagnostics Reveals
March 29, 2016
 · 
1 min read
Birth Of The $1 Diarrhea Vaccine
March 28, 2016
 · 
1 min read
Long Naps, Daytime Sleepiness Tied To Heart Risks, University of Tokyo Reveals
March 28, 2016
 · 
3 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Business
Bay Area’s XenoPort Snags Psoriasis and MS Deal Worth $490 Million+ from Dr. Reddy’s Laboratories Ltd.
March 28, 2016
 · 
3 min read
Here’s Why 5 Billionaire-Led Funds Gobbled Up 3.3 Million Shares of Celldex Stock
Bio NC
6 Cheap Biopharma Stocks to Consider
March 25, 2016
 · 
3 min read
China’s Vaccine Scandal Reveals System’s Flaws
March 25, 2016
 · 
1 min read
A Simple Diagnostic Blood Test For Breast Cancer, Macquarie University Reveals
March 23, 2016
 · 
1 min read
Load More
PRESS RELEASES
Press Releases
Ellipses In-Licenses First-in-Class B7H3 Antibody Drug Conjugate From China
January 23, 2026
 · 
2 min read
Press Releases
Mabwell Announces First-Patient Dosed in Clinical Trial of Novel CDH17-Targeting ADC 7MW4911 in the U.S.
January 23, 2026
 · 
4 min read
Press Releases
SK bioscience, MSD, and Hilleman Laboratories Advance Zaire ebolavirus Vaccine Development with CEPI Funding
January 23, 2026
 · 
4 min read
Press Releases
SINOVAC Announces Nasdaq Hearings Panel Grants Continued Listing
January 22, 2026
 · 
3 min read
Press Releases
Daiichi Sankyo Appoints New Leadership at the Daiichi Sankyo Translational Research Center Europe
January 22, 2026
 · 
3 min read
Press Releases
AB Science receives Japanese patent protection for the use of masitinib in progressive forms of multiple sclerosis (MS) until 2041
January 22, 2026
 · 
10 min read
Press Releases
Hoth Therapeutics Secures Major International Patent Milestone for HT-KIT Cancer Program, Strengthening Global Oncology IP Position
January 21, 2026
 · 
5 min read
Press Releases
ProImmune Introduces Mastering Immunity 2026 - Shanghai Symposium to Address Key Immunogenicity Challenges
January 21, 2026
 · 
2 min read
Press Releases
Samsung Biologics reports fourth quarter and fiscal year 2025 financial results
January 21, 2026
 · 
5 min read
Press Releases
HistoIndex Partners with Houston Research Institute to Expand Advanced MASH Diagnostic Services
January 21, 2026
 · 
3 min read
Press Releases
Syngene International extends long-term research collaboration with Bristol Myers Squibb until 2035
January 21, 2026
 · 
4 min read
Press Releases
Dyne Therapeutics Receives Orphan Drug Designation in Japan for Zeleciment Basivarsen (DYNE-101) for Myotonic Dystrophy Type 1
January 20, 2026
 · 
7 min read
Press Releases
LakeShore Biopharma to Hold Extraordinary General Meeting of Shareholders
January 20, 2026
 · 
6 min read
Press Releases
Ascletis Selects a Next-Generation Once-Monthly Subcutaneously Administered GLP-1R/GIPR/GCGR Triple Peptide Agonist, ASC37, for Clinical Development
January 20, 2026
 · 
4 min read
Press Releases
Nxera Pharma Establishes Metabolic Advisory Council to Advance Next-Generation Therapies for Obesity and Metabolic Disorders
January 20, 2026
 · 
6 min read
Press Releases
LexBio Named One of Ten “Honored Enterprises” in NVIDIA Inception Showcase 2025
January 19, 2026
 · 
1 min read
Press Releases
FDA Grants Regenerative Medicine Advanced Therapy (RMAT) Designation to iRegene’s NouvNeu001, Making It the World’s First iPSC Therapy with Both FTD and RMAT Recognitions
January 19, 2026
 · 
5 min read
Press Releases
Akeso Announces NMPA Acceptance of Second NDA for Gumokimab (IL-17A Inhibitor) in Active Ankylosing Spondylitis
January 19, 2026
 · 
4 min read
Press Releases
ENHERTU® Plus Pertuzumab Type II Variation Application Validated in the EU as First-Line Treatment of Patients with HER2 Positive Metastatic Breast Cancer
January 19, 2026
 · 
10 min read
Press Releases
Nxera Pharma Reports Positive Results From Phase 3 Trial of Daridorexant in South Korea
January 19, 2026
 · 
7 min read
Load More